A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis.

Soon, D; Altmann, DR; Fernando, KT; Giovannoni, G; Barkhof, F; Polman, CH; O'connor, P; Gray, B; Panzara, M; Miller, DH; (2007) A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis. Journal of neurology, 254 (3). pp. 306-14. ISSN 0340-5354 DOI: https://doi.org/10.1007/s00415-006-0356-z

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1007/s00415-006-0356-z

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar